324 related articles for article (PubMed ID: 31810126)
1. Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles.
Wu M; Mei F; Liu W; Jiang J
Biomed Pharmacother; 2020 Jan; 121():109637. PubMed ID: 31810126
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of Tumor-Infiltrating CD49a
Sun H; Liu L; Huang Q; Liu H; Huang M; Wang J; Wen H; Lin R; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
Cancer Immunol Res; 2019 Sep; 7(9):1535-1546. PubMed ID: 31311791
[TBL] [Abstract][Full Text] [Related]
3. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
[TBL] [Abstract][Full Text] [Related]
4. Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes.
Shin S; Kim M; Lee SJ; Park KS; Lee CH
Cancer Genomics Proteomics; 2017; 14(5):349-362. PubMed ID: 28871002
[TBL] [Abstract][Full Text] [Related]
5. Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.
Sun H; Huang Q; Huang M; Wen H; Lin R; Zheng M; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
Hepatology; 2019 Jul; 70(1):168-183. PubMed ID: 30411378
[TBL] [Abstract][Full Text] [Related]
6. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma.
Cui Z; Li H; Liu C; Wang J; Chen C; Hu S; Zhao X; Li G
Aging (Albany NY); 2024 Apr; 16(7):6550-6565. PubMed ID: 38604154
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells.
Hu J; Wang E; Liu L; Wang Q; Xia D; Bai W; Tie J; Li X; Yuan J; Yang S; Jiang D; Shi J; Sun Y; Wang J; Zhang C; Niu J; Li K; He C; Guo W; Lv Y; Chen H; Yuan X; Yu T; Wang Z; Luo B; Han N; Zhu Y; Yin Z; Fan D; Zhang Z; Yang K; Han G
Invest New Drugs; 2020 Oct; 38(5):1247-1256. PubMed ID: 31832851
[TBL] [Abstract][Full Text] [Related]
8. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
Zhang PF; Gao C; Huang XY; Lu JC; Guo XJ; Shi GM; Cai JB; Ke AW
Mol Cancer; 2020 Jun; 19(1):110. PubMed ID: 32593303
[TBL] [Abstract][Full Text] [Related]
9. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
[TBL] [Abstract][Full Text] [Related]
10. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma.
Chew V; Chen J; Lee D; Loh E; Lee J; Lim KH; Weber A; Slankamenac K; Poon RT; Yang H; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Abastado JP
Gut; 2012 Mar; 61(3):427-38. PubMed ID: 21930732
[TBL] [Abstract][Full Text] [Related]
11. Expression of inhibitory receptors in natural killer (CD3(-)CD56(+)) cells and CD3(+)CD56(+) cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma.
Yuen MF; Norris S
Clin Immunol; 2001 Dec; 101(3):264-9. PubMed ID: 11726217
[TBL] [Abstract][Full Text] [Related]
12. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
Su Z; Ye X; Shang L
Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients.
Chew V; Tow C; Huang C; Bard-Chapeau E; Copeland NG; Jenkins NA; Weber A; Lim KH; Toh HC; Heikenwalder M; Ng IO; Nardin A; Abastado JP
J Natl Cancer Inst; 2012 Dec; 104(23):1796-807. PubMed ID: 23197495
[TBL] [Abstract][Full Text] [Related]
14. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib attenuated the function of natural killer cells infiltrated in HCC through inhibiting ERK1/2.
Li C; Wei S; Xu X; Jiang Y; Xue L; Jiang P; Wang J
Int Immunopharmacol; 2019 Nov; 76():105855. PubMed ID: 31472321
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells.
Bugide S; Green MR; Wajapeyee N
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3509-E3518. PubMed ID: 29581297
[TBL] [Abstract][Full Text] [Related]
17. Quantitative effect of natural killer-cell licensing on hepatocellular carcinoma recurrence after curative hepatectomy.
Tanimine N; Tanaka Y; Kobayashi T; Tashiro H; Miki D; Imamura M; Aikata H; Tanaka J; Chayama K; Ohdan H
Cancer Immunol Res; 2014 Dec; 2(12):1142-7. PubMed ID: 25135909
[TBL] [Abstract][Full Text] [Related]
18. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.
Cai L; Zhang Z; Zhou L; Wang H; Fu J; Zhang S; Shi M; Zhang H; Yang Y; Wu H; Tien P; Wang FS
Clin Immunol; 2008 Dec; 129(3):428-37. PubMed ID: 18824414
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic significance of natural killer cell infiltration in hepatocellular carcinoma].
Zhu LY; Zhou J; Liu YZ; Pan WD
Ai Zheng; 2009 Nov; 28(11):1198-202. PubMed ID: 19895742
[TBL] [Abstract][Full Text] [Related]
20. RAC1
Shi X; Chen W; Yin Y; Cao H; Wang X; Jiang W; Li Q; Li X; Yu Y; Wang X
Cancer Lett; 2024 Jun; 592():216909. PubMed ID: 38679407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
